Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study

BACKGROUND: Levels of bone turnover markers (BTM) might be correlated with outcome in terms of skeletal-related events (SRE), disease progression, and death in patients with bladder cancer (BC) and renal cell carcinoma (RCC) with bone metastases (BM). We try to evaluate this possible correlation in...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcaraz, A, González-López, R, Morote, J, de la Piedra, C, Meseguer, C, Esteban, E, Climent, M, González-Gragera, B, Álvarez-Ossorio, J-L, Chirivella, I, Mellado, B, Lara, P-C, Vázquez, F, Contreras, J-A, Carles, J, Murias, A, Calderero, V, Comet-Batlle, J, González-del Alba, A, León-Mateos, L, Mañas, A, Segarra, J, Lassa, A, González-Enguita, C, Méndez, M-J, Samper, P, Unda, M, Mahillo-Fernández, I, Bellmunt, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708561/
https://www.ncbi.nlm.nih.gov/pubmed/23799855
http://dx.doi.org/10.1038/bjc.2013.272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708561/
https://www.ncbi.nlm.nih.gov/pubmed/23799855
http://dx.doi.org/10.1038/bjc.2013.272

Ejemplares similares